50 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
named executive officers during the fiscal years ended December 31, 2023 and December 31, 2022:
NAMEAND PRINCIPAL POSITION
YEAR
SALARY
BONUS
STOCK … of common stock.
Represents bonus paid in February 2024 based upon 2023 corporate performance, as approved by our Compensation Committee or Board
8-K
g9k hmikswrh5g
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
ys6awzph7jj5vofg0
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.3
idlon
26 Jun 20
Other Events
5:08pm
8-K
0aaxgeicidu5kuuq1
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
90ps6mvevua4l z2
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
wehbpt pho8
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
fpxjo4
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
mo2 ba6ah1n
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-2.1
jt9upigwpf
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-2.1
1yvffp 1g6
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
qqdmb4ca
12 Sep 19
Cost Associated with Exit or Disposal Activities
5:19pm